LISATA THERAPEUTICS, INC. Accretion Expense
LISATA THERAPEUTICS, INC. (LSTA) reported Accretion Expense of $232.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2020-03-05
- LISATA THERAPEUTICS, INC. accretion expense for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. accretion expense for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. accretion expense for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. accretion expense for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. accretion expense for fiscal 2019 was $232.00K, a 17.73% decline from fiscal 2018.
- LISATA THERAPEUTICS, INC. accretion expense for fiscal 2018 was $282.00K, a 17.06% decline from fiscal 2017.
- LISATA THERAPEUTICS, INC. accretion expense for fiscal 2017 was $340.00K.
- LISATA THERAPEUTICS, INC. accretion expense for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month | Accretion Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $232.00K 10-K · filed 2020-03-05 | ||||
| 2018-12-31 | $282.00K 10-K · filed 2020-03-05 | ||||
| 2017-12-31 | $340.00K 10-K · filed 2019-03-14 | $339.96K 10-K · filed 2018-03-22 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $0.00 derived: sum of 2 quarters · filed 2018-03-22 | $0.00 derived: sum of 3 quarters · filed 2018-03-22 | $0.00 10-K · filed 2018-03-22 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | $0.00 10-Q · filed 2016-11-07 | $17.52K derived: sum of 4 quarters · filed 2017-03-17 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | $17.52K derived: sum of 3 quarters · filed 2017-03-17 | $62.04K derived: sum of 4 quarters · filed 2017-03-17 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | $17.52K derived: sum of 2 quarters · filed 2017-03-17 | $62.04K derived: sum of 3 quarters · filed 2017-03-17 | $65.37K derived: sum of 4 quarters · filed 2017-03-17 | |
| 2015-12-31 | $17.52K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $62.04K derived: sum of 2 quarters · filed 2017-03-17 | $65.37K derived: sum of 3 quarters · filed 2017-03-17 | $95.09K 10-K · filed 2017-03-17 | |
| 2015-09-30 | $44.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $47.85K derived: sum of 2 quarters · filed 2016-11-07 | $77.58K 10-Q · filed 2016-11-07 | $121.77K derived: sum of 4 quarters · filed 2016-11-07 | |
| 2015-06-30 | $3.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $33.05K 10-Q · filed 2016-08-09 | $77.24K derived: sum of 3 quarters · filed 2016-08-09 | $84.57K derived: sum of 4 quarters · filed 2016-08-09 | |
| 2015-03-31 | $29.72K 10-Q · filed 2016-05-05 | $73.91K derived: sum of 2 quarters · filed 2016-05-05 | $81.24K derived: sum of 3 quarters · filed 2016-05-05 | $81.24K derived: sum of 4 quarters · filed 2016-05-05 | |
| 2014-12-31 | $44.19K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $51.52K derived: sum of 2 quarters · filed 2016-03-15 | $51.52K derived: sum of 3 quarters · filed 2016-03-15 | $51.52K 10-K · filed 2016-03-15 | |
| 2014-09-30 | $7.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $7.33K derived: sum of 2 quarters · filed 2015-11-05 | $7.33K 10-Q · filed 2015-11-05 | $7.33K derived: sum of 4 quarters · filed 2016-03-15 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-06 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 10-K · filed 2016-03-15 | |||
| 2013-09-30 | $0.00 10-Q · filed 2014-10-30 | ||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |